The CBOE EuroCurrency Volatility Index ("Euro VIX", Ticker - EVZ) measures the market's expectation of 30-day volatility of the $US/Euro exchange rate by applying the VIX methodology to options on the CurrencyShares Euro Trust (Ticker - FXE). Like other VIX benchmarks, EVZ uses options spanning a wide range of strike prices.
Euro VIX is just one in a series of new volatility indexes based on new asset classes, marking the next generation of VIX benchmarks. CBOE currently calculates the CBOE Crude Oil Volatility Index (OVX) based on United States Oil Fund (USO) option prices; and also the CBOE Gold Volatility Index (GVZ) based on SPDR Gold Shares (GLD) options.
FXE is an exchange-traded fund (ETF) that holds Euro on-demand deposits in Euro-denominated bank accounts. As such, the performance of FXE is intended to reflect the $US/Euro exchange rate, less fund expenses. Following is a chart comparing FXE prices with the spot Euro exchange rate.
FXE options were first listed on May 9, 2007; CBOE began trading FXE options on January 10, 2008. Today, FXE options are growing in popularity, averaging over 3,000 contracts per day, industry-wide, through July 2008.
For more information and Euro VIX historical prices since November 1, 2007, please see below.
CBOE EuroCurrency Volatility Index historical prices
Options involve risk and are not suitable for all
investors. Prior to buying or selling an option, a person must receive a copy
of Characteristics and Risks of Standardized
Options (ODD). Copies of the ODD are available from your broker, by
calling 1-888-OPTIONS, or from The Options Clearing Corporation, One North
Wacker Drive, Suite 500, Chicago, Illinois 60606. The information on this
website is provided solely for general education and information purposes and
therefore should not be considered complete, precise, or current. Many of the
matters discussed are subject to detailed rules, regulations, and statutory
provisions which should be referred to for additional detail and are subject to
changes that may not be reflected in the website information. No statement
within the website should be construed as a recommendation to buy or sell a
security or to provide investment advice. The inclusion of non-CBOE
advertisements on the website should not be construed as an endorsement or an
indication of the value of any product, service, or website. The
Terms and Conditions govern use of this website and use of this website
will be deemed acceptance of those Terms and Conditions.